Researchers studied the use of phytochemicals from medicinal plants to prevent cardiovascular diseases, including lowering cholesterol and controlling diabetes. More research is needed to fully understand their effectiveness.
G. pentaphyllum is an herb with potential anti-obesity properties, but its mechanism is unclear. Research needed for insight into treating obesity and related conditions.
Goldenroot (GP) has potential in treating type 2 diabetes mellitus (T2DM). GP contains 32 components and 326 potential targets related to T2DM, acting through insulin resistance signaling pathways. GP extracts increased glucose uptake and glycogen synthesis, suggesting a potential therapy for T2DM.
Study on Gypenosides (GYPs) in Thunb. Makino plant shows potential for anti-aging and treating age-related conditions like diabetes. GYPs preserve mitochondrial function and prevent heart failure. Important for cardiovascular health research.
Gynostemma pentaphyllum gypenosides show promise in treating neuropsychiatric disorders. More research needed for clinical applications. Important for potential neuroprotective properties and improving human health.
Gypenoside A from Gynostemma pentaphyllum protects heart cells from ischemia/reperfusion injury by regulating circ_0010729/miR-370-3p/RUNX1 axis. Potential treatment for cardiovascular disease.
Gypenoside induces apoptosis in gastric cancer cells, inhibits PI3K/AKT/mTOR pathway, and reduces PD-L1 expression. Enhances antitumor immunity of T cells. Potential new therapeutic agent for immunotherapy in gastric cancer.
Saponins from plants and marine life show promise for anti-inflammatory therapies via molecular actions like NF-κB regulation. They shape the gut microbiome, impacting immune regulation and metabolic health, suggesting potential dietary interventions for chronic inflammation.
Researchers investigated the potential anti-esophageal cancer effects of Gynostemma pentaphyllum Thunb. Makino. Understanding its active components and mechanisms can lead to improved treatment options for esophageal cancer.
Researchers found that nine dammarane triterpenoids have significant inhibitory activity on protein tyrosine phosphatase 1B, indicating their potential as treatments for type 2 diabetes.
seedlings of an important medicinal herb were exposed to cadmium (Cd) stress. They showed enhanced antioxidant activity and accumulation of certain metabolites. Genetic analysis identified key genes and metabolic pathways involved. Understanding this response mechanism can help develop varieties with low Cd accumulation.
Scientists cloned and expressed a gene encoding an enzyme that converts ginsenoside Rb1 into gypenoside XVII, a compound with improved anti-inflammatory activity. This method has potential for large-scale production of gypenoside XVII as a new anti-inflammatory drug.
This study evaluated the prevalence and characteristics of adverse events associated with adaptogen-antidepressant interactions. Adaptogens were involved in 9% of adverse events. Clinicians should monitor these interactions due to the potential for clinically significant adverse events.
Gynostemma pentaphyllum is a plant that can be used for medicine and tea. It contains flavonoids and saponins and has various positive effects, including lowering cholesterol, fighting cancer, protecting the heart and liver, as well as offering neuroprotection, antidiabetic, and anti-inflammatory benefits.
New gypenosides derived from Gynostemma pentaphyllum have potential as anti-fibrotic agents for treating chronic hepatic disorders, particularly hepatic fibrosis. Compound 5 shows promise in mitigating hepatic fibrosis in mice.
Gynostemma pentaphyllum extract shows promise in reducing cognitive impairment in Alzheimer's disease. A specific compound from the extract, NPLC0393, targets a protein called PPM1A, reducing inflammation and tau hyperphosphorylation, and improving communication between microglia and neurons.
This study investigates how heat-processed G. pentaphyllum affects lipid metabolism in hyperlipidemic conditions, which is relevant for understanding its potential as a treatment option.
This review examines how medicinal plants can help manage obesity, which is a growing global health problem associated with serious health conditions.
In a study, Gypenoside LXXV (GP-75), a natural plant compound, was administered to mice with Alzheimer's disease and diabetes. GP-75 improved cognitive function, glucose control, and insulin sensitivity in the mice. It also reduced beta-amyloid buildup in the brain and increased glucose uptake. The treatment worked by activating certain signaling pathways in the brain. These findings suggest that GP-75 has potential for treating cognitive impairment in humans with Alzheimer's and diabetes.
Chinese medicinal herb Gynostemma Pentaphyllum (Thunb.) Makino (GpM) has been reported to ameliorate cognitive impairment in Alzheimer's disease (AD), but its neuroprotective mechanism remains unclear. Researchers aimed to investigate the targets and possible signaling pathways of GpM in the treatment of AD. GpM's anti-inflammatory, anti-oxidative stress, and anti-tumor properties make it a promising candidate for AD drug treatment.